Bipolar disorder associated to substance use disorders (dual diagnosis). Systematic review of the scientific evidence and expert consensus

Actas Espanolas de Psiquiatria

Volumn 36, Issue 6, 2008, Pages 350-361

  Casas, Miguel ^a   Franco, M D ^b   Goikolea, J M ^c   Jimenez Arriero M A ^d   Martinez Raga J ^e   Roncero, C ^a   Szerman, N ^f  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^b UNIVERSITY OF SEVILLE   (Spain)

^c HOSPITAL CLÍNIC   (Spain)

^d HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^e UNIVERSIDAD CEU CARDENAL HERRERA   (Spain)

^f HOSPITAL UNIVERSITARIO INFANTA LEONOR   (Spain)

Author keywords

Bipolar disorder; Dual diagnosis; Expert consensus; Scientific evidence; Substance dependence

Indexed keywords

ADDICTION; BIPOLAR DISORDER; EXPERT WITNESS; HUMAN; PSYCHIATRIC DIAGNOSIS; REVIEW;

BIPOLAR DISORDER; DIAGNOSIS, DUAL (PSYCHIATRY); EXPERT TESTIMONY; HUMANS; SUBSTANCE-RELATED DISORDERS;

EID: 57349099942     PISSN: 11399287     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (46)

1. Krishnan KRR. Psychiatric and medical comorbidities of bipolar disorder. Psychosom Med 2005:67:1-8.
2. Akiskal HS, Bourgeois ML, Angst J, Post R, Möller H, Hirschfeld R. Re-evaluating the prevalence of and diagnostic composition within the broad clinical spectrum of bipolar disorders. J Affect Disord 2000;59(Suppl. 1):S5-S30.
3. Regier DA, Farmer ME, Rae DS, Locke BZ, Keith SJ, Judd LL, et al. Comorbidity of mental disorders with alcohol and other drug abuse. Results from the epidemiologic catchment area (ECA) study. JAMA 1990;264:2511-8.
4. Merikangas KR, Akiskal HS, Angst J, Greenberg PE, Hirschfeld RMA, Petukhova M, et al. Lifetime and 12 month prevalence of bipolar spectrum disorder in the national comorbidity survey replication. Arch Gen Psychiatry 2007;64:543-52.
5. OEDT. Observatorio europeo de las drogas y toxicomanias. Informe anual 2005. El problema de las drogodependencia en Europa. Luxemburgo: oficina de las comunidades europeas. Online edition, 2005.
6. Swann AC, Anderson JC, Dougherty DM, Moeller FG. Measurement of inter-episode impulsivity in bipolar disorder. Psychiatry Res 2001;101:195-7.
7. Winokur G, Coryell W, Akiskal HS, Maser JD, Keller MB, Endicott J, et al. Alcoholism in manic-depressive (bipolar) illness: familial illness, course of illness, and the primary-secondary distinction. Am J Psychiatry 1995;152:365-72.
8. Kranzler HR, del Boca FK, Rounsaville BJ. Comorbid psychiatric diagnosis predicts 3 year outcomes in alcoholics: a posttreatment natural history study. J Stud Alcohol 1996;57:619-26.
9. Goldberg JF, Garno JL, Leon AC, Kocsis JH, Portera L. A history of substance abuse complicates remission from acute mania in bipolar disorder. J Clin Psychiatry 1999;60:733-40.
10. Dalton EJ, Cate-Carter TD, Mundo E, Parikh SV, Kennedy JL Suicide risk in bipolar patients: the role of co-morbid substance use disorders. Bipolar Disord 2003;5:58-61.
11. Das AK, Olfson M, Gameroff MJ, Pilowsky DJ, Blanco C, Feder A, et al. Screening for bipolar disorder in a primary care practice. JAMA 2005;293:956-63.
12. Brady KT, Sonne SC. The relationship between substance abuse and bipolar disorder. J Clin Psychiatry 1995;56 Suppl. 3:19-24.
13. Brown SE, Suples T, Adinoff B, Thomas NR. Drug abuse and bipolar disorder: comorbidity or misdiagnosis? J Affective Dis 2001;65:105-15.
14. Feinman JA, Dunner DL. The effect of alcohol and substance abuse on the course of bipolar affective disorder. J Affect Disord 1996;37:43-9.
15. Strakowski SM, DelBello MP, Fleck DE, Adler CM, Anthenelli RM, Keck PEJ, et al. Effects of co-occurring alcohol abuse on the course of bipolar disorder following a first hospitalization for mania. Arch Gen Psychiatry 2005;62:851-8.
16. Goodwin FK. Anticonvulsant therapy and suicide risk in affective disorders. J Clin Psychiatry 1999;60(Suppl. 2):89-93; discussion 111-6.
17. Weiss RD, Ostacher MJ, Otto MW, Calabrese JR, Fossey M, Wisniewski, et al. Does recovery from substance use disorder matter in patients with bipolar disorder? J Clin Psychiatry 2005;66:730-5;808-9.
18. Rush AJ. Toward an understanding of bipolar disorder and its origin. J Clin Psychiatry 2003;64(Suppl. 6):4-8;discussion 28.
19. Sloan KL, Rowe G. Substance abuse and psychiatric illness: treatment experience. Am J Drug Alcohol Abuse 1998;24:589-601.
20. Kupka RW, Nolen WA, Altshuler L, Denicoff KD. Preliminary summary of demographics, course of illness and response to novel treatments. Br J Psychiatry 2001;178(Suppl. 4):177-83.
21. Weiss RD, Greenfield SF, Najavits LM, Soto JA, Wyner D, Tohen M, et al. Medication compliance among patients with bipolar disorder and substance use disorder. J Clin Psychiatry 1998;59: 172-4.
22. Geller B, Cooper TB, Sun K, Zimerman B, Frazier J, Williams M, et al. Double-blind and placebo-controlled study of lithium for adolescent bipolar disorders with secondary substance dependency. J Am Acad Child Adolesc Psychiatry 1998;37:171-8.
23. Gawin FH, Kleber HD. Cocaine abuse treatment, open pilot trial with desipramine and lithium carbonate. Arch Gen Psychiatry 1984;41:903-9.
24. Nunes EV, McGrath PJ, Wager S, Quitkin FM. Lithium treatment for cocaine abusers with bipolar spectrum disorders. Am J Psychiatry 1990;147:655-7.
25. Salloum IM, Cornelius JR, Daley DC, Kirisci L, Himmelhoch JM, Thase ME. Efficacy of valproate maintenance in patients with bipolar disorder and alcoholism: a double-blind placebo-controlled study. Arch Gen Psychiatry 2005;62:37-45.
26. Hammer BA, Brady KT. Valproate treatment of alcohol withdrawal and mania. Am J Psychiatry 1996;153:1232.
27. Halikas J, Kemp K, Kuhn K. Preliminary indication of differential treatment responsiveness to carbamazepine for cocaine addiction, based on differential personality psychopathology. Biol psychiatry 1989;25:13A.
28. Brady KT, Sonne SC, Malcolm RJ, Randall CL, Dansky BS, Simpson K, et al. Carbamazepine in the treatment of cocaine dependence: subtyping by affective disorder. Exp Clin Psychopharmacol 2002;10:276-85.
29. Perugi G, Toni C, Frare F, Ruffolo G, Moretti L, Torti C, et al. Effectiveness of adjunctive gabapentin in resistant bipolar disorder: is it due to anxious-alcohol abuse comorbidity J Clin Psychopharmacol 2002;22:584-91.
30. Brown ES, Nejtek VA, Perantie DC, Orsulak PJ, Bobadilla L. Lamotrigine in patients with bipolar disorder and cocaine dependence. J Clin Psychiatry 2003;64:197-201.
31. Grof P. Selecting effective long-term treatment for bipolar patients: monotherapy and combinations. J Clin Psychiatry 2003;64(Suppl 5):53-61.
32. Passmore MJ, Garnham J, Duffy A, MacDougall M, Munro A, Slaney C, et al. Phenotypic spectra of bipolar disorder in responded to lithium versus lamotrigine. Bipolar Disord 2003;5:110-4.
33. Brunette MF, Noordsy DL, Xie H, Drake RE. Benzodiazepine use and abuse among patients with severe mental illness and co-occurring substance use disorders. Psychiatr Serv 2003;54:1395-401.
34. Clark RE, Xie H, Brunette MF. Benzodiazepine prescription practices and substance abuse in persons with severe mental illness. J Clin Psychiatry 2004;65:151-5.
35. Brown ES, Nejtek VA, Perantie DC, Bobadilla L. Quetiapine in bipolar disorder and cocaine dependence. Bipolar Disord 2002;4:406-11.
36. Longoria J, Brown ES, Perantie DC, Bobadilla L, Nejtek VA. Quetiapine for alcohol use and craving in bipolar disorder. J Clin Psychopharmacol 2004;24:101-2.
37. Potvin S, Stip E, Roy J. The effect of quetiapine on cannabis use in 8 psychosis patients with drug dependency. Can J Psychiatry 2004;49:711.
38. Brown ES, Jeffress J, Liggin JDM, Garza M, Beard L. Switching outpatients with bipolar or schizoaffective disorders and substance abuse from their current antipsychotic to aripiprazole. J Clin Psychiatry 2005;66:756-60.
39. Raimo EB, Schuckit MA. Alcohol dependence and mood disorders. Addict Behav 1998;23:933-46.
40. Kampman KM, Pettinati H, Lynch KG, Dackis C, Sparkman T, Weigley C, et al. A pilot trial of topiramate for the treatment of cocaine dependence. Drug Alcohol Depend 2004;75:233-40.
41. Johnson BA, Ait-Daoud N, Bowden CL, DiClemente CC, Roache JD, Lawson K, et al. Oral topiramate for treatment of alcohol dependence: a randomised controlled trial. Lancet 2003;361:1677-85.
42. Dackis CA, Kampman KM, Lynch KG, Pettinati HM, O'Brien CP. A double-blind, placebo-controlled trial of modafinil for cocaine dependence. Neuropsychopharmacology 2005;30:205-11.
43. Frye MA, Grunze H, Suppes T, McElroy SL, Keck PEJ, Walden J, et al. A placebo-controlled evaluation of adjunctive modafinil in the treatment of bipolar depression. Am J Psychiatry 2007;164:1242-9.
44. Colom F, Vieta E. A perspective on the use of psychoeducation, cognitive-behavioral therapy and interpersonal therapy for bipolar patients. Bipolar Disord 2004;6:480-6.
45. Weiss RD, Griffin ML, Kolodziej ME, Greenfield SF, Najavits LM, Daley DC, et al. A randomized trial of integrated group therapy versus group drug counseling for patients with bipolar disorder and substance dependence. Am J Psychiatry 2007;164:100-7.
46. Salloum IM, Weiss RD. Managing alcohol and substance abuse in patients with bipolar disorder. Seventh International Conference on Bipolar Disorder. Pittsburgh, USA, 2007.